In the BioHarmony Drug Report Database

"Preview" Icon

Vincristine

Marqibo, Oncovin (vincristine) is a small molecule pharmaceutical. Vincristine was first approved as Marqibo on 1982-01-01. It is used to treat hodgkin disease, leukemia, neuroblastoma, non-hodgkin lymphoma, and rhabdomyosarcoma amongst others in the USA. The pharmaceutical is active against tubulin beta chain.

 

Trade Name

 

Marqibo, Oncovin
 

Common Name

 

vincristine
 

ChEMBL ID

 

CHEMBL90555
 

Indication

 

hodgkin disease, leukemia, neuroblastoma, non-hodgkin lymphoma, rhabdomyosarcoma, wilms tumor
 

Drug Class

 

Vinca alkaloids

Image (chem structure or protein)

Vincristine structure rendering